Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Change in Receivables (2022 - 2025)

Historic Change in Receivables for Coeptis Therapeutics Holdings (COEP) over the last 3 years, with Q3 2025 value amounting to $52500.0.

  • Coeptis Therapeutics Holdings' Change in Receivables changed N/A to $52500.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $52500.0, marking a year-over-year change of. This contributed to the annual value of -$8075.0 for FY2023, which is 20000.0% down from last year.
  • Per Coeptis Therapeutics Holdings' latest filing, its Change in Receivables stood at $52500.0 for Q3 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Change in Receivables peaked at $52500.0 during Q3 2025, and registered a low of -$8075.0 during Q1 2023.
  • In the last 3 years, Coeptis Therapeutics Holdings' Change in Receivables had a median value of $8075.0 in 2022 and averaged $17500.0.